How big is the Nucleic Acid Based Therapeutics Market?

The Nucleic Acid Based Therapeutics Market size is expected to reach USD 5.59 billion in 2024 and grow at a CAGR of 14.29% to reach USD 10.90 billion by 2029. Read More

What is the current Nucleic Acid Based Therapeutics Market size?

In 2024, the Nucleic Acid Based Therapeutics Market size is expected to reach USD 5.59 billion. Read More

Who are the key players in Nucleic Acid Based Therapeutics Market?

Silence Therapeutics plc, Ionis Pharmaceuticals, Inc. , Novartis Pharma AG , Sarepta Therapeutics, Inc. and Alnylam Pharmaceuticals, Inc. are the major companies operating in the Nucleic Acid Based Therapeutics Market. Read More

Which is the fastest growing region in Nucleic Acid Based Therapeutics Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Nucleic Acid Based Therapeutics Market?

In 2024, the North America accounts for the largest market share in Nucleic Acid Based Therapeutics Market. Read More

What years does this Nucleic Acid Based Therapeutics Market cover, and what was the market size in 2023?

In 2023, the Nucleic Acid Based Therapeutics Market size was estimated at USD 4.89 billion. The report covers the Nucleic Acid Based Therapeutics Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Nucleic Acid Based Therapeutics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Nucleic Acid Based Therapeutics Market Share

Statistics for the 2023 & 2024 Nucleic Acid Based Therapeutics market share, created by Mordor Intelligence™ Industry Reports. Nucleic Acid Based Therapeutics share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Nucleic Acid Based Therapeutics Industry

The nucleic acid-based therapeutics market is moderately fragmented due to the presence of many small and large players globally and regionally. The companies are engaging in the research and development of nucleic acid-based therapeutics for the treatment of various chronic, genetic, and infectious diseases. Some of the key companies in the market are Silence Therapeutics PLC, Ionis Pharmaceuticals Inc., Sarepta Therapeutics, Novartis Pharma AG, Alnylam Pharmaceuticals Inc., and Biogen Inc., among others.